A Randomized, Double-blind, Vehicle-controlled Phase 1 Dermal Safety Study Using a 21 Day Cumulative Irritant Patch Test Design to Evaluate the Local Tolerability of Azelaic Acid Pre-Foam Formulation in Healthy Volunteers
A Randomized, Double-blind, Vehicle-controlled Phase 1 Dermal Safety Study Using a 21 Day Cumulative Irritant Patch Test Design to Evaluate the Local Tolerability of Azelaic Acid Pre-Foam Formulation in Healthy Volunteers
The purpose of this study is to determine the irritancy potential of azelaic acid pre-foam formulation.
This is the standard patch test over 21 days of exposure of the test product,its vehicle and a positive as well as a negative control.
Inclusion Criteria:
Exclusion Criteria: